Lilly planning $3B expansion of Wisconsin plant to boost production

Eli Lilly (NYSE:LLY) plans to boost production of its popular diabetes and weight-loss medications with a $3B expansion of its recently acquired manufacturing facility in Kenosha County, Wisconsin.

Lilly expects to start construction on the expansion in 2025, noting that it